SCHEMBL10275627

SCHEMBL10275627

CCOC(=O)c1c(O)[nH]c2c(-c3ccc(C(=O)O)cc3)c(C)nn2c1=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.41
ALDH1A1 P00352 5/20 0.41
KDM4E B2RXH2 4/20 0.41
HPGD P15428 3/20 0.41
LMNA P02545 3/20 0.41
GAA P10253 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
TSHR P16473 2/20 0.40
PLAT P00750 2/20 0.40
HTT P42858 2/20 0.40
POLB P06746 2/20 0.39
SLC11A2 P49281 1/20 0.39
THRB P10828 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2C9 P11712 1/20 0.38
KMT2A Q03164 3/20 0.37
MEN1 O00255 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10313456 0.90 MAPT (0.44) MAPTALDH1A1KDM4EHPGDLMNA
SCHEMBL10313590 0.90 MAPT (0.52) MAPTALDH1A1KDM4EHPGDLMNA
SCHEMBL10276177 0.86 MAPT (0.44) MAPTALDH1A1KDM4EPLATHTT
SCHEMBL10275830 0.85 AR (0.42) MAPTALDH1A1KDM4EHPGDLMNA
SCHEMBL10313571 0.80 CYP1A2 (0.39) MAPTALDH1A1KDM4EHPGDLMNA
SCHEMBL10313580 0.80 MAT2A (0.50) MAPTALDH1A1KDM4EHPGDLMNA
SCHEMBL10275463 0.78 GPR119 (0.44) MAPTALDH1A1KDM4EHPGDLMNA
SCHEMBL10276175 0.77 MAPT (0.44) MAPTALDH1A1KDM4ELMNASMN1; SMN2
SCHEMBL10275179 0.77 PLAT (0.40) MAPTALDH1A1KDM4EHPGDLMNA
SCHEMBL10313589 0.77 ALDH1A1 (0.48) MAPTALDH1A1KDM4EHPGDLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120178915-A1 PYRIMIDINE DERIVATIVES AND ANALOGS, PREPARATION METHOD AND USE THEREOF XU LIFENG (US) 2012-07-12 US claimed
US-20120178915-A1 PYRIMIDINE DERIVATIVES AND ANALOGS, PREPARATION METHOD AND USE THEREOF XU LIFENG (US) 2012-07-12 US disclosed
WO-2011035518-A1 PYRIMIDINE DERIVATIVES AND ANALOGS, PREPARATION METHOD AND USE THEREOF 辽宁利锋科技开发有限公司 (CN) 2011-03-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120178915-A1 PYRIMIDINE DERIVATIVES AND ANALOGS, PREPARATION METHOD AND USE THEREOF TYMP, TYMS, ADORA3 MAPT 750/4885ALDH1A1 572/4885KDM4E 3483/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.